BIRC5 and B-cell chronic lymphocytic leukemia: A statistically significant increase in all patients with CLL during the dietary intervention was observed (p ≤0.05) in ccK18 and Apo1-Fas and also a statistically significant decrease in Survivin after 3 months which remained after 6 months (Table 4).